Information Provided By: 
Fly News Breaks for January 4, 2017
TMO, A
Jan 4, 2017 | 05:45 EDT
Barclays analyst Jack Meehan upgraded Agilent Technologies (A) to Overweight saying strength in biopharma and a new gas chromatography product cycle can drive improved growth. The analyst raised his price target for the shares to $51 from $48. Meehan adds that Thermo Fisher (TMO) remains his top pick in U.S. Life Science Tools & Diagnostics. The analyst lowered his view of the sector to Neutral from Positive as he sees a more balanced set-up in the near-term.
News For A;TMO From the Last 2 Days
TMO
Apr 25, 2024 | 08:51 EDT
Deutsche Bank raised the firm's price target on Thermo Fisher to $610 from $600 and keeps a Buy rating on the shares post the Q1 report. The analyst says a solid operational performance drove a strong start to 2024.
TMO
Apr 25, 2024 | 08:29 EDT
TMO
Apr 25, 2024 | 07:32 EDT
TMO
Apr 25, 2024 | 07:03 EDT
TMO
Apr 25, 2024 | 06:31 EDT
TMO
Apr 25, 2024 | 05:12 EDT
Barclays analyst Luke Sergott raised the firm's price target on Thermo Fisher to $615 from $590 and keeps an Equal Weight rating on the shares. The company reported a beat across the board, says the analyst, who sees the business stabilizing.
TMO
Apr 24, 2024 | 08:50 EDT
Check out this morning's top movers from around Wall Street, compiled by The Fly. UP AFTER EARNINGS... To see the rest of the story go to thefly.com. See Story Here
TMO
Apr 24, 2024 | 06:11 EDT
TMO
Apr 24, 2024 | 06:09 EDT
TMO
Apr 24, 2024 | 06:02 EDT
